Literature DB >> 26314566

High prevalence of elevated blood pressure among children with neurofibromatosis type 1.

Tom Dubov1,2, Hagit Toledano-Alhadef1,2, Gil Chernin1,3, Shlomi Constantini1,2, Roxana Cleper1,4, Shay Ben-Shachar5,6.   

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is a common neurocutaneous disease characterized by café-au-lait spots, axillary and inguinal freckling, neurofibromas, and optic gliomas. Increased rates of hypertension (HTN) were reported among NF1 patients, however, the prevalence of HTN and pre-HTN in pediatric NF1 patients has not been clarified.
METHODS: Blood pressure (BP) measurements, weight, and renal ultrasound were assessed in 224 NF1 pediatric patients followed in a specialized NF1 clinic.
RESULTS: The cohort's mean age was 9.1 ± 4.1 years. Overweight and obesity were found in 12.9 and 10.3 % of them, respectively. BP was measured averagely 2.9 times per patient on different occasions. Blood pressure was in the pre-HTN and HTN ranges in 14.9 and 16.9 % of measurements, respectively. BP >95th was detected in 20.5 % at the first measurement. Of 114 children with at least three BP measurements, 18.4 % had two values in the HTN range and 6.14 % had at least three. Overweight was not associated with HTN among children with NF1. Urinary tract ultrasonographic abnormalities were detected in 6.8 % (11/161) of cases.
CONCLUSIONS: The prevalence of increased BP in pediatric NF1 is much higher than in the general pediatric population. BP has to be regularly assessed and managed in this high-risk population.

Entities:  

Keywords:  Hypertension; NF1; Obesity; Pre-hypertension; Renal ultrasound

Mesh:

Year:  2015        PMID: 26314566     DOI: 10.1007/s00467-015-3191-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  33 in total

1.  Comparison of the automated non-invasive oscillometric blood pressure monitor (BpTRU) with the auscultatory mercury sphygmomanometer in a paediatric population.

Authors:  Gurdial S Mattu; Balraj S Heran; James M Wright
Journal:  Blood Press Monit       Date:  2004-02       Impact factor: 1.444

Review 2.  Type 1 neurofibromatosis and the pediatric patient.

Authors:  V M Riccardi
Journal:  Curr Probl Pediatr       Date:  1992-02

3.  Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma.

Authors:  Birke Bausch; Wiktor Borozdin; Hartmut P H Neumann
Journal:  N Engl J Med       Date:  2006-06-22       Impact factor: 91.245

4.  Validation of the Welch Allyn Spot Vital Signs blood pressure device according to the ANSI/AAMI SP10: 2002. Accuracy and cost-efficiency successfully combined.

Authors:  Bruce S Alpert
Journal:  Blood Press Monit       Date:  2007-10       Impact factor: 1.444

5.  Renal Doppler evaluation in the child with hypertension: a reasonable screening discriminator?

Authors:  Sumit Chhadia; Richard A Cohn; Gulsah Vural; James S Donaldson
Journal:  Pediatr Radiol       Date:  2013-07-17

6.  Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.

Authors:  Bonnie Kaas; Thierry A G M Huisman; Aylin Tekes; Amanda Bergner; Jaishri O Blakeley; Lori C Jordan
Journal:  J Child Neurol       Date:  2012-07-25       Impact factor: 1.987

7.  Blood pressure and cardiovascular involvement in children with neurofibromatosis type1.

Authors:  Giuliana Lama; Luisa Graziano; Elvira Calabrese; Carolina Grassia; Pier Francesco Rambaldi; Fabrizio Cioce; Michele Adolfo Tedesco; Giovanni Di Salvo; Maria Esposito-Salsano
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

8.  Prevalence of hypertension and pre-hypertension among adolescents.

Authors:  Karen L McNiece; Timothy S Poffenbarger; Jennifer L Turner; Kathy D Franco; Jonathan M Sorof; Ronald J Portman
Journal:  J Pediatr       Date:  2007-06       Impact factor: 4.406

Review 9.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

Review 10.  Hypertension in children and adolescents: epidemiology and natural history.

Authors:  Bonita Falkner
Journal:  Pediatr Nephrol       Date:  2009-05-07       Impact factor: 3.714

View more
  6 in total

1.  Ask-Upmark kidney in a girl with neurofibromatosis type 1.

Authors:  Yuri Dote; Tetsuya Kibe; Tomotaka Murakami; Midori Awazu
Journal:  CEN Case Rep       Date:  2020-04-10

Review 2.  Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.

Authors:  Shivani Ahlawat; Jaishri O Blakeley; Shannon Langmead; Allan J Belzberg; Laura M Fayad
Journal:  Skeletal Radiol       Date:  2019-08-08       Impact factor: 2.199

3.  Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage.

Authors:  Arttu Kurtelius; Roope A Kallionpää; Jukka Huttunen; Terhi J Huttunen; Katariina Helin; Timo Koivisto; Juhana Frösen; Mikael von Und Zu Fraunberg; Sirkku Peltonen; Juha Peltonen; Juha E Jääskeläinen; Antti E Lindgren
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

4.  Rare complications of neurofibromatosis 1 diagnosed incidentally in two children.

Authors:  Cecilia Lazea; Carmen Asavoaie; Camelia Al-Khzouz; Lenuta Popa
Journal:  Ther Clin Risk Manag       Date:  2018-08-31       Impact factor: 2.423

5.  Arterial Stiffness in a Toddler with Neurofibromatosis Type 1 and Refractory Hypertension.

Authors:  Stella Stabouli; Euthymia Vargiami; Olga Maliachova; Nikoleta Printza; John Dotis; Maria Kyriazi; Konstantinos O Papazoglou; Dimitrios Zafeiriou
Journal:  Case Rep Pediatr       Date:  2018-10-31

6.  Identification of NF1 Frameshift Variants in Two Chinese Families With Neurofibromatosis Type 1 and Early-Onset Hypertension.

Authors:  Yi-Ting Lu; Di Zhang; Xin-Chang Liu; Qiong-Yu Zhang; Xue-Qi Dong; Peng Fan; Yan Xiao; Xian-Liang Zhou
Journal:  Front Pediatr       Date:  2021-12-20       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.